Surgical treatment of non-small-cell lung cancer in octogenarians: a single-centre retrospective study

被引：7
|
作者：
Chen, Charlotte [1 ]
Kolbe, John [1 ,2 ]
Christmas, Tim [1 ]
机构：
[1] Auckland Dist Hlth Board, Resp Serv, Auckland, New Zealand
[2] Univ Auckland, Dept Med, Auckland, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 04期
关键词：
lung cancer; octogenarian; lung resection; ELDERLY-PATIENTS; RISK;
D O I：
10.1111/imj.15268
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lung resection in patients aged >= 80 years is considered high risk and contributes to the low rates of resection in this population. This review of 79 octogenarians who underwent curative surgery for non-small-cell lung cancer demonstrated no intraoperative mortality, 30-day mortality of 1.3% and 12-month mortality of 10%. In this selected cohort of octogenarians, surgery resulted in acceptable short- to medium-term outcomes.
引用
收藏
页码：596 / 599
页数：4
相关论文
共 50 条
  • [41] Systemic treatment of non-small-cell lung cancer
    Lal, Rohit
    Enting, Deborah
    Kristeleit, Hartmut
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S375 - S377
  • [42] Medical treatment of non-small-cell lung cancer
    Buter, J
    Giaccone, G
    ANNALS OF ONCOLOGY, 2005, 16 : 229 - 232
  • [43] Crizotinib for the treatment of non-small-cell lung cancer
    Timm, Andrew
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (11) : 943 - 947
  • [44] Pemetrexed in the treatment of non-small-cell lung cancer
    Cash, R.
    Dangoor, A.
    LUNG CANCER, 2015, 87 : S27 - S27
  • [45] A REVELation in non-small-cell lung cancer treatment?
    Mok, Tony S. K.
    Loong, Herbert H.
    LANCET, 2014, 384 (9944): : 640 - 642
  • [46] Trastuzumab for the treatment of non-small-cell lung cancer
    Ferrone, M
    Motl, SE
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1904 - 1908
  • [47] The systemic treatment of non-small-cell lung cancer
    Propper, D
    Talbot, DC
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 285 - 290
  • [48] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
    Vozy, A.
    Zalcman, G.
    ONCOLOGIE, 2015, 17 (09) : 407 - 408
  • [49] Gemcitabine for the treatment of non-small-cell lung cancer
    Johnson, DH
    ONCOLOGY-NEW YORK, 2001, 15 (03): : 33 - 39
  • [50] Crizotinib in the treatment of non-small-cell lung cancer
    Forde, Patrick M.
    Rudin, Charles M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1195 - 1201
12345